Novel endoscopic approaches in the diagnosis and management of biliary strictures

Indeterminate bilary strictures present the clinician with a wide differential diagnosis. Histological confirmation is usually required for treatment, but tissue acquisition remains challenging. Novel developments in endoscopic technology, such as single operator cholangioscopy and confocal endomicroscopy, have led to improvements in diagnostic accuracy in recent years. In patients with non-resectable malignant biliary obstruction, effective biliary decompression improves symptoms and enables patients to undergo palliative therapies. Improvements in endoscopic techniques, biliary stents and the development of local ablative techniques have led to further improvements in stent patency and survival in these patients. In this article, we review emerging diagnostic and therapeutic techniques for the endoscopic management of indeterminate biliary strictures.

[1]  Jesse S. Voss,et al.  Primary sclerosing cholangitis with equivocal cytology: Fluorescence in situ hybridization and serum CA 19‐9 predict risk of malignancy , 2013, Cancer cytopathology.

[2]  Shahid A. Khan,et al.  The palliation of cholangiocarcinoma , 2013, Current opinion in supportive and palliative care.

[3]  A. Ruzzenente,et al.  Role of Preoperative Biliary Drainage in Jaundiced Patients Who Are Candidates for Pancreatoduodenectomy or Hepatic Resection: Highlights and Drawbacks , 2013, Annals of surgery.

[4]  M. Hartleb,et al.  Differentiation of pancreatobiliary cancer from benign biliary strictures using neutrophil gelatinase-associated lipocalin. , 2013, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[5]  M. Wang,et al.  Comparative Proteomic Profiling of Human Bile Reveals SSP411 as a Novel Biomarker of Cholangiocarcinoma , 2012, PloS one.

[6]  S. Pereira Photodynamic therapy for pancreatic and biliary tract cancer: the United Kingdom experience. , 2012, Journal of the National Comprehensive Cancer Network : JNCCN.

[7]  J. K. Lee,et al.  A comparison of bilateral stenting methods for malignant hilar biliary obstruction. , 2012, Hepato-gastroenterology.

[8]  Alexander Meining,et al.  Direct visualization of indeterminate pancreaticobiliary strictures with probe-based confocal laser endomicroscopy: a multicenter experience. , 2011, Gastrointestinal endoscopy.

[9]  B. Petersen,et al.  Single-operator cholangioscopy in patients requiring evaluation of bile duct disease or therapy of biliary stones (with videos). , 2011, Gastrointestinal endoscopy.

[10]  Yoshiki Narimatsu,et al.  A novel serum carbohydrate marker on mucin 5AC , 2011, Cancer.

[11]  J. Dooley,et al.  Circulating CYFRA 21-1 is a Specific Diagnostic and Prognostic Biomarker in Biliary Tract Cancer. , 2011, Journal of clinical and experimental hepatology.

[12]  S. G. Bown,et al.  Photodynamic therapy of pancreatic cancer and elastic scattering spectroscopy of the duodenal mucosa for the detection of pancreaticobiliary malignancy , 2011, BiOS.

[13]  J. Hwang,et al.  Y-shaped endoscopic bilateral metal stent placement for malignant hilar biliary obstruction: prospective long-term study , 2011, Scandinavian journal of gastroenterology.

[14]  H. Pitt,et al.  Role of EUS for preoperative evaluation of cholangiocarcinoma: a large single-center experience. , 2011, Gastrointestinal endoscopy.

[15]  A. Postgate,et al.  Endoscopically applied radiofrequency ablation appears to be safe in the treatment of malignant biliary obstruction. , 2011, Gastrointestinal endoscopy.

[16]  G. Monges,et al.  Results of a phase I–II study on intraductal confocal microscopy (IDCM) in patients with common bile duct (CBD) stenosis , 2011, Surgical Endoscopy.

[17]  L. Lara,et al.  Endoscopic ultrasound-guided transduodenal placement of a fully covered metal stent for palliative biliary drainage in patients with malignant biliary obstruction , 2011, Surgical Endoscopy.

[18]  E. Jonas,et al.  Covered versus uncovered self- expandable nitinol stents in the palliative treatment of malignant distal biliary obstruction: results from a randomized, multicenter study , 2010, Journal of Digestive Endoscopy.

[19]  K. Leelawat,et al.  Prospective study of MMP7 serum levels in the diagnosis of cholangiocarcinoma. , 2010, World journal of gastroenterology.

[20]  Myung-Hwan Kim,et al.  EUS-guided hepaticogastrostomy with a fully covered metal stent as the biliary diversion technique for an occluded biliary metal stent after a failed ERCP (with videos). , 2010, Gastrointestinal endoscopy.

[21]  D. Gouma,et al.  Preoperative biliary drainage for cancer of the head of the pancreas. , 2010, The New England journal of medicine.

[22]  G. Gores,et al.  Long‐term outcomes of positive fluorescence in situ hybridization tests in primary sclerosing cholangitis , 2010, Hepatology.

[23]  T. Sauerbruch,et al.  Combination of bilateral metal stenting and trans-stent photodynamic therapy for palliative treatment of hilar cholangiocarcinoma. , 2010, Zeitschrift fur Gastroenterologie.

[24]  R. Passariello,et al.  Percutaneous Treatment of Malignant Jaundice Due to Extrahepatic Cholangiocarcinoma: Covered Viabil Stent Versus Uncovered Wallstents , 2010, CardioVascular and Interventional Radiology.

[25]  Y. G. Li,et al.  Clinical significance of serum tumour M2-PK and CA19-9 detection in the diagnosis of cholangiocarcinoma. , 2009, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[26]  Sumio Watanabe,et al.  Early detection of extrahepatic bile-duct carcinomas in the nonicteric stage by using MRCP followed by EUS. , 2009, Gastrointestinal endoscopy.

[27]  T. Itoi,et al.  Cholangioscopy by using narrow-band imaging and transpapillary radiotherapy for mucin-producing bile duct tumor. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[28]  C. Yoon,et al.  Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach. , 2009, Gastrointestinal endoscopy.

[29]  C. Prinz,et al.  Detection of cholangiocarcinoma in vivo using miniprobe-based confocal fluorescence microscopy. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[30]  Lingyun Huang,et al.  Serum levels of variants of transthyretin down‐regulation in cholangiocarcinoma , 2008, Journal of cellular biochemistry.

[31]  G. Williams,et al.  Diagnosis of pancreaticobiliary malignancy by detection of minichromosome maintenance protein 5 in bile aspirates , 2008, British Journal of Cancer.

[32]  R. Kiesslich,et al.  Methylene blue-aided cholangioscopy in patients with biliary strictures: feasibility and outcome analysis , 2008, Endoscopy.

[33]  M. Syu,et al.  Diagnostic role of biliary pancreatic elastase for cholangiocarcinoma in patients with cholestasis. , 2008, Clinica chimica acta; international journal of clinical chemistry.

[34]  G. Gores,et al.  EUS-guided FNA of regional lymph nodes in patients with unresectable hilar cholangiocarcinoma. , 2008, Gastrointestinal endoscopy.

[35]  R. Kiesslich,et al.  Methylene blue-aided cholangioscopy unravels the endoscopic features of ischemic-type biliary lesions after liver transplantation. , 2007, Gastrointestinal endoscopy.

[36]  W. Lees,et al.  Autoimmune Pancreatitis: Clinical and Radiological Features and Objective Response to Steroid Therapy in a UK Series , 2007, The American Journal of Gastroenterology.

[37]  A. Franchitto,et al.  Serum and Biliary Insulin-like Growth Factor I and Vascular Endothelial Growth Factor in Determining the Cause of Obstructive Cholestasis , 2007, Annals of Internal Medicine.

[38]  Takayoshi Tsuchiya,et al.  Peroral cholangioscopic diagnosis of biliary-tract diseases by using narrow-band imaging (with videos). , 2007, Gastrointestinal endoscopy.

[39]  Y. S. Kim,et al.  Diagnostic Utility of Interleukin-6 (IL-6) for Primary Bile Duct Cancer and Changes in Serum IL-6 Levels Following Photodynamic Therapy , 2007, The American Journal of Gastroenterology.

[40]  T. Chattopadhyay,et al.  Differentiation between benign and malignant hilar obstructions using laboratory and radiological investigations: a prospective study. , 2007, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[41]  J. Llach,et al.  Comparison of Endoscopic Ultrasonography and Magnetic Resonance Cholangiopancreatography in the Diagnosis of Pancreatobiliary Diseases: A Prospective Study , 2007, The American Journal of Gastroenterology.

[42]  P. Macmathuna,et al.  Malignant distal biliary obstruction: a systematic review and meta-analysis of endoscopic and surgical bypass results. , 2007, Cancer treatment reviews.

[43]  G. Gores,et al.  Advanced cytologic techniques for the detection of malignant pancreatobiliary strictures. , 2006, Gastroenterology.

[44]  B. Petersen,et al.  Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[45]  T. Kamisawa,et al.  Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease , 2006, Journal of Gastroenterology.

[46]  A. Larghi,et al.  Endoscopic direct cholangioscopy by using an ultra-slim upper endoscope: a feasibility study. , 2006, Gastrointestinal endoscopy.

[47]  M. Manns,et al.  Cholangioscopic Characterization of Dominant Bile Duct Stenoses in Patients with Primary Sclerosing Cholangitis , 2006, Endoscopy.

[48]  M. D'Angelica,et al.  Clinical and pathologic features of proximal biliary strictures masquerading as hilar cholangiocarcinoma. , 2005, Journal of the American College of Surgeons.

[49]  D. Apel,et al.  Palliation of Nonresectable Bile Duct Cancer: Improved Survival After Photodynamic Therapy , 2005, The American Journal of Gastroenterology.

[50]  G. Gores,et al.  The Value of Serum CA 19-9 in Predicting Cholangiocarcinomas in Patients with Primary Sclerosing Cholangitis , 2005, Digestive Diseases and Sciences.

[51]  Troels Z. Kristiansen,et al.  Mac‐2‐binding protein is a diagnostic marker for biliary tract carcinoma , 2004, Cancer.

[52]  T. Baron,et al.  Prospective, Blinded Assessment of Factors Influencing the Accuracy of Biliary Cytology Interpretation , 2004, American Journal of Gastroenterology.

[53]  Y. Shiratori,et al.  A prospective randomised study of “covered” versus “uncovered” diamond stents for the management of distal malignant biliary obstruction , 2004, Gut.

[54]  J. McCall,et al.  Differential Diagnosis of Stenosing Lesions at the Hepatic Hilus , 2004, World Journal of Surgery.

[55]  T. Therneau,et al.  A prospective comparison of digital image analysis and routine cytology for the identification of malignancy in biliary tract strictures. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[56]  Min Lu,et al.  Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: in comparison with CEA. , 2004, World journal of gastroenterology.

[57]  M. Dotti,et al.  Hepaticogastrostomy by Echo-Endoscopy as a Palliative Treatment in a Patient with Metastatic Biliary Obstruction , 2003, Endoscopy.

[58]  S. Shiesh,et al.  The value of biliary fibronectin for diagnosis of cholangiocarcinoma. , 2003, Hepato-gastroenterology.

[59]  M. Freeman,et al.  Selective MRCP and CT-targeted drainage of malignant hilar biliary obstruction with self-expanding metallic stents. , 2003, Gastrointestinal endoscopy.

[60]  S. Sherman,et al.  Tissue sampling at ERCP in suspected malignant biliary strictures (Part 2). , 2002, Gastrointestinal endoscopy.

[61]  S. Shiesh,et al.  The assessment of biliary CA 125, CA 19-9 and CEA in diagnosing cholangiocarcinoma--the influence of sampling time and hepatolithiasis. , 2002, Hepato-gastroenterology.

[62]  K. McMasters,et al.  Cost comparison of endoscopic stenting vs surgical treatment for unresectable cholangiocarcinoma , 2002, Surgical Endoscopy.

[63]  R. Felix,et al.  Magnetic resonance cholangiopancreatography-guided unilateral endoscopic stent placement for Klatskin tumors. , 2001, Gastrointestinal endoscopy.

[64]  M. V. Varas Lorenzo,et al.  [Interventional endoscopic ultrasonography]. , 2001, Gastroenterologia y hepatologia.

[65]  A. Bergquist,et al.  Can DNA cytometry be used for evaluation of malignancy and premalignancy in bile duct strictures in primary sclerosing cholangitis? , 2000, Journal of hepatology.

[66]  G. Gores Early detection and treatment of cholangiocarcinoma , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[67]  N. Chalasani,et al.  Cholangiocarcinoma in patients with primary sclerosing cholangitis: A multicenter case‐control study , 2000, Hepatology.

[68]  C. Poremba,et al.  Preoperative diagnosis of bile duct strictures--comparison of intraductal ultrasonography with conventional endosonography. , 2000, Scandinavian journal of gastroenterology.

[69]  K. Schupak,et al.  Palliation of irresectable hilar cholangiocarcinoma with biliary drainage and radiotherapy , 1995, The British journal of surgery.

[70]  Roger Williams,et al.  Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. , 1995, Gastroenterology.

[71]  P. Cotton,et al.  Randomised trial of endoscopic steriting versus surgical bypass in malignant low bileduct obstruction , 1994, The Lancet.

[72]  R. W. Cox,et al.  Primary gelatinous drop-like keratopathy. , 1989, The British journal of ophthalmology.

[73]  D. Brinkley,et al.  Treatment of hilar carcinoma by bile drainage combined with internal radiotherapy using 192iridium wire , 1983, The British journal of surgery.